✓ checked
trust me, bro:
here is the receipt.
the claim
Semaglutide, sold as Ozempic, reduces obstructive sleep apnea severity.
the verdict
CONTESTED PARTIAL
Recorded sources
1 source for · 1 against
Is it true that Semaglutide, sold as Ozempic, reduces obstructive sleep apnea severity?
Partly. One review asserts semaglutide has a clinical impact on obstructive sleep apnea management, while a meta-analysis notes semaglutide has not been evaluated in any randomized controlled trials specifically targeting OSA. Neither item reports a measured reduction in OSA severity from semaglutide itself.
Verdict: CONTESTED PARTIAL · 1 source for, 1 against · Last checked
Evidence for · 1
Get citation
Gentile, S., Satta, E., & Guarino, G. (2026). THE THERAPEUTIC POTENTIAL OF INCRETIN-BASED THERAPIES AND THE EMERGING ROLE OF METABOLIC MODULATION IN THE MANAGEMENT OF OBSTRUCTIVE SLEEP APNEA: A MECHANISTIC AND CLINICAL REVIEW. zenodo.org. https://doi.org/10.5281/zenodo.21370777
Evidence against · 1
Get citation
Efficacy of GLP-1 Receptor agonists in treating Obstructive sleep apnea: A systematic review and meta-analysis of cardiometabolic and respiratory outcomes - PMC Lock. (n.d.). pmc.ncbi.nlm.nih.gov. https://doi.org/10.1007/s11325-026-03681-4
Receipt History
Anyone with this link can read the claim and its public receipt, including any
personal information in that text. Open permanent receipt.
Check your own claim
Challenge the receipt
Requests are recorded for review. This does not start an automatic check
or guarantee a response time.
Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.
This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work
Terms · Privacy · How verdicts work